These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3483342)

  • 1. [Tumoricidal activity of neutrophils].
    Gavioli R; Spisani S; Giuliani AL; Traniello S
    Boll Soc Ital Biol Sper; 1987 Nov; 63(11):1059-65. PubMed ID: 3483342
    [No Abstract]   [Full Text] [Related]  

  • 2. Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes.
    Abrams SI; Brahmi Z
    J Immunol; 1984 Jun; 132(6):3192-6. PubMed ID: 6327820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of tumour cell destruction by PMA-activated human neutrophils.
    Dallegri F; Frumento G; Patrone F
    Immunology; 1983 Feb; 48(2):273-9. PubMed ID: 6295926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungicidal activity of human neutrophils and monocytes on dermatophyte fungi, Trichophyton quinckeanum and Trichophyton rubrum.
    Calderon RA; Hay RJ
    Immunology; 1987 Jul; 61(3):289-95. PubMed ID: 3610211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging of neutrophils to target cells by opsonized zymosan enhances the cytotoxicity of neutrophil-produced H2O2.
    Jiang X; Wu TH; Rubin RL
    J Immunol; 1997 Sep; 159(5):2468-75. PubMed ID: 9278340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing.
    Martin JH; Edwards SW
    J Immunol; 1993 Apr; 150(8 Pt 1):3478-86. PubMed ID: 8385686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hydroxyl radical in neutrophil-mediated cytotoxicity.
    Umeda T; Hara T; Hayashida M; Niijima T
    Cell Mol Biol; 1985; 31(3):229-33. PubMed ID: 2990716
    [No Abstract]   [Full Text] [Related]  

  • 8. The myeloperoxidase-hydrogen peroxide-halide system as effector of neutrophil-mediated tumor cell cytotoxicity.
    Clark RA; Szot S
    J Immunol; 1981 Apr; 126(4):1295-301. PubMed ID: 6259257
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of neutrophil inflammatory mediator release: chemotactic peptide activation of stimulus-dependent cytotoxicity.
    English D; Lukens JN
    J Immunol; 1983 Feb; 130(2):850-6. PubMed ID: 6294178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of reactive oxygen metabolites onto and within living tumor cells during neutrophil-mediated antibody-dependent cellular cytotoxicity.
    Cao D; Boxer LA; Petty HR
    J Cell Physiol; 1993 Aug; 156(2):428-36. PubMed ID: 8344997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidocaine inhibits macrophage mediated cytotoxicity and enhances neutrophil mediated cytotoxicity.
    Cameron DJ
    Jpn J Exp Med; 1986 Dec; 56(6):265-9. PubMed ID: 3599491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressed neutrophil-mediated tumor cell cytotoxicity in subjects affected by hereditary myeloperoxidase deficiency and secondary neoplasia.
    Lanza F; Giuliani AL; Amelotti F; Spisani S; Traniello S; Castoldi G
    Haematologica; 1988; 73(5):355-8. PubMed ID: 2848754
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for a nonoxidative mechanism of human natural killer (NK) cell cytotoxicity by using mononuclear effector cells from healthy donors and from patients with chronic granulomatous disease.
    Kay HD; Smith DL; Sullivan G; Mandell GL; Donowitz GR
    J Immunol; 1983 Oct; 131(4):1784-8. PubMed ID: 6311897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil-mediated mammalian tumor cell cytotoxicity: role of the peroxidase system.
    Jong EC; Klebanoff SJ
    J Immunol; 1980 Apr; 124(4):1949-53. PubMed ID: 7365245
    [No Abstract]   [Full Text] [Related]  

  • 15. Phorbol myristate acetate induced neutrophil autotoxicity.
    Tsan MF
    J Cell Physiol; 1980 Nov; 105(2):327-34. PubMed ID: 7193215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemically-defined differentiation markers on human early haemopoietic (K562) cells.
    Turberville C; Horton MA
    Biomed Pharmacother; 1984; 38(6):311-4. PubMed ID: 6596961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
    Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an oxidation-resistant tumor cell line and its sensitivity to immune response and chemotherapy.
    Sauri H; Kim AT; Shau H
    J Surg Res; 1995 May; 58(5):526-35. PubMed ID: 7745966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHA-induced neutrophil-mediated cytotoxicity.
    Dallegri F; Frumento G; Maggi A; Patrone F
    J Clin Lab Immunol; 1983 Aug; 11(4):203-6. PubMed ID: 6199502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist and antagonist of oxygen free radical.
    Ogata H; Midorikawa Y
    Can J Anaesth; 1990 May; 37(4 Pt 2):S104. PubMed ID: 2361243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.